Polytrauma and Resuscitation Impact on Innate Immunity

NCT ID: NCT06314841

Last Updated: 2024-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

62 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-01

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major trauma can lead to a dysregulated response to secondary infection. Severe injuries are accompanied by pro- and antiinflammatory changes that affect both adaptive and innate immunity. In this study we aim to assess cellular immuno-competence early during treatment in an attempt to identify signs of immuno-suppression.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Polytrauma represents one of the most challenging critical conditions for caretakers worldwide and involves multiple damages of different anatomical regions. Severe traumatic injuries are among the primary causes of death among young people under the age of 45 and half of them are due to uncontrollable bleeding. In the acute injury phase of trauma, severe blood loss is often accompanied by biochemical, cellular and physiological dysfunctions leading to an inflammatory response, infections and in some cases coagulopathy. We aim to identify immuno-suppression by analyzing phagocytic capacity, leukocyte subsets, surface molecule expression and extracellular vesicles in the peripheral blood of severly injured patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wounds and Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18
* Injury Severity Score (ISS) \> 15
* Incident to admission time \< 3h

Exclusion Criteria

* Preexisting condition
* Pregnancy or breastfeeding
* Diabetes
* Coronary Heart Disease
* Intake of antiphlogistic medication
* Neoplasm
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AUVA

OTHER

Sponsor Role collaborator

Ludwig Boltzmann Gesellschaft

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gerhard Fritsch

Priv.-Doz., Prim., Dr.med.univ

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susanne Drechsler, DVM

Role: STUDY_CHAIR

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology

Marcin Osuchowski, DVM

Role: STUDY_CHAIR

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology

Heinz Steltzer, MD, Prof.

Role: STUDY_CHAIR

Trauma Center Vienna, Meidling

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trauma Center Vienna, Meidling

Vienna, , Austria

Site Status

Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Center

Vienna, , Austria

Site Status

Trauma Center Vienna, Lorenz Böhler

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LBG-AUVA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multi-Institutional IMPACT Validation
NCT06850857 ENROLLING_BY_INVITATION